Keywords: solvay, first-half, profit, declines, belgian, drugs, chemicals
Solvay's first-half 2008 profit declines 15%
Article | 11 August 2008
Belgian drugs and chemicals firm Solvay Pharmaceuticals says net income totaled 351.0 million euros ($557.7 million) in first-half 2008, a 15% decline year-on-year, taking ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
